Presentation is loading. Please wait.

Presentation is loading. Please wait.

Curcumin suppresses the expression of antiapoptotic proteins in multiple myeloma cells. Curcumin suppresses the expression of antiapoptotic proteins in.

Published byShinta Jayadi Modified over 5 years ago

Similar presentations

Presentation on theme: "Curcumin suppresses the expression of antiapoptotic proteins in multiple myeloma cells. Curcumin suppresses the expression of antiapoptotic proteins in."— Presentation transcript:

1 Curcumin suppresses the expression of antiapoptotic proteins in multiple myeloma cells.
Curcumin suppresses the expression of antiapoptotic proteins in multiple myeloma cells. A, curcumin suppresses Akt activation in U266 cells. U266 cells (2 × 106/mL) were treated with 50 μmol/L curcumin for the indicated times. Whole-cell extracts were prepared, separated on SDS-PAGE, and subjected to Western blot analysis using the indicated proteins. The same blots were stripped and reprobed with Akt antibody to show equal protein loading. B, curcumin inhibits the expression of antiapoptotic gene products. U266 cells (2 × 106/mL) were treated with 50 μmol/L curcumin for the indicated times. Whole-cell extracts were prepared, separated on SDS-PAGE, and subjected to Western blot analysis using the indicated proteins. The same blots were stripped and reprobed with β-actin antibody to show equal protein loading. Bokyung Sung et al. Mol Cancer Ther 2009;8: ©2009 by American Association for Cancer Research

Download ppt "Curcumin suppresses the expression of antiapoptotic proteins in multiple myeloma cells. Curcumin suppresses the expression of antiapoptotic proteins in."

Similar presentations

CDK2 is highly expressed in colon cancer cells and curcumin selectively suppresses HCT116 cell proliferation. CDK2 is highly expressed in colon cancer.

CDK2 is highly expressed in colon cancer cells and curcumin selectively suppresses HCT116 cell proliferation. CDK2 is highly expressed in colon cancer.
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to.

Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to.
FAS1 domain protein inhibits association of αvβ3 integrin with VEGFR-2 and attenuates VEGF165-induced VEGFR-2 phosphorylation. FAS1 domain protein inhibits.

FAS1 domain protein inhibits association of αvβ3 integrin with VEGFR-2 and attenuates VEGF165-induced VEGFR-2 phosphorylation. FAS1 domain protein inhibits.
NM-3 induces p21 levels and down-regulation of Cdk2 activity.

NM-3 induces p21 levels and down-regulation of Cdk2 activity.
A, Western blot analysis of fetuin-A in AGA (lanes 1–5 and 10–13) and IUGR (lanes 6–9, 14, and 15) UC plasma samples. A, Western blot analysis of fetuin-A.

A, Western blot analysis of fetuin-A in AGA (lanes 1–5 and 10–13) and IUGR (lanes 6–9, 14, and 15) UC plasma samples. A, Western blot analysis of fetuin-A.
Interfering with HMGA2 expression blocks transformation in metastatic lung cancer cells. Interfering with HMGA2 expression blocks transformation in metastatic.

Interfering with HMGA2 expression blocks transformation in metastatic lung cancer cells. Interfering with HMGA2 expression blocks transformation in metastatic.
p38 MAPK activation is required for phosphorylation of Akt at Ser473.

p38 MAPK activation is required for phosphorylation of Akt at Ser473.
Antibody specificity ascertained by 2D-PAGE Western immunoblotting (IEF) of total cellular protein extracts from the RT4 human bladder cancer cell line.

Antibody specificity ascertained by 2D-PAGE Western immunoblotting (IEF) of total cellular protein extracts from the RT4 human bladder cancer cell line.
Western blotting analysis of purified cytoplasmic membranes.

Western blotting analysis of purified cytoplasmic membranes.
Overexpression of BTAK/Aurora-A in ovarian carcinoma.

Overexpression of BTAK/Aurora-A in ovarian carcinoma.
Expression changes of specific epigenetic-controlled tumor-related genes by the prenatal/maternal BSp treatment. qRT-PCR and Western blot analysis were.

Expression changes of specific epigenetic-controlled tumor-related genes by the prenatal/maternal BSp treatment. qRT-PCR and Western blot analysis were.
Thiocolchicoside inhibits TNF-dependent IκBα phosphorylation, IκBα degradation, p65 phosphorylation, and p65 nuclear translocation. Thiocolchicoside inhibits.

Thiocolchicoside inhibits TNF-dependent IκBα phosphorylation, IκBα degradation, p65 phosphorylation, and p65 nuclear translocation. Thiocolchicoside inhibits.
GF103209X attenuates PKC, MEK and ERK 1/2 phosphorylation in laminarin-challenged haemocytes. GF103209X attenuates PKC, MEK and ERK 1/2 phosphorylation.

GF103209X attenuates PKC, MEK and ERK 1/2 phosphorylation in laminarin-challenged haemocytes. GF103209X attenuates PKC, MEK and ERK 1/2 phosphorylation.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.

Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
The p53 pathway is involved in the inhibition of cell proliferation observed in 15-LOX-1-overexpressing cells. The p53 pathway is involved in the inhibition.

The p53 pathway is involved in the inhibition of cell proliferation observed in 15-LOX-1-overexpressing cells. The p53 pathway is involved in the inhibition.
CML-HSA treatment activates MAPK family members ERK1/2 and p38 but not JNK. Samples were taken at the indicated times after 100 μg/ml CML-HSA exposure.

CML-HSA treatment activates MAPK family members ERK1/2 and p38 but not JNK. Samples were taken at the indicated times after 100 μg/ml CML-HSA exposure.
Curcumin-generated ROS activates Chk1 and Chk2 kinases.

Curcumin-generated ROS activates Chk1 and Chk2 kinases.
The sesquiterpene lactone PN up-regulates MDM2 and p53 proteins.

The sesquiterpene lactone PN up-regulates MDM2 and p53 proteins.
Quantification of NMT knockdown.

Quantification of NMT knockdown.
VHL-, oxygen-, and proteasome-dependent regulation of AUF1 expression in RCC and 293T cells. VHL-, oxygen-, and proteasome-dependent regulation of AUF1.

VHL-, oxygen-, and proteasome-dependent regulation of AUF1 expression in RCC and 293T cells. VHL-, oxygen-, and proteasome-dependent regulation of AUF1.

Similar presentations

Ads by Google